ArticleAmerican journal of clinical oncology2010

A phase I trial of oblimersen sodium in combination with cisplatin and 5-fluorouracil in patients with advanced esophageal, gastroesophageal junction, and gastric carcinoma.

Rachel Raab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.